Aug 2026· Nature Neuroscience· Vol 29, pp. 2341 - 2354· 0 citations· 52 references
Medicine
TL;DR
E engineered HTR2A mouse lines enabling in vivo mapping, targeting and modulation of receptor-expressing neurons are developed and validated their utility across biochemical, electrophysiological and behavioral studies of psychedelic mechanisms.
Abstract
Psychedelic drugs, such as lysergic acid diethylamide and psilocybin, have emerged as potentially transformative therapeutics for various neuropsychiatric conditions, including depression, anxiety, post-traumatic stress disorder, migraine and cluster headaches. Classical psychedelics exert their effects through activation of 5-hydroxytryptamine 2A receptors (HTR2As). Here we provide a suite of engineered mice that will be useful for clarifying the role of HTR2A in psychedelic drug actions. We generated Htr2aEGFP-CreERT2 mice to identify both HTR2A-EGFP-CT receptors and HTR2A-containing cells, thereby revealing HTR2A distribution in the brain. We also generated humanized Htr2aA242S−EGFP-Cre and constitutive Htr2aCre mice. Psychedelic-induced behavioral changes in these mice validated their utility for these studies. Electrophysiological investigations on brain sections from these mice revealed that 2,5,-dimethoxy-4-iodoamphetamine induced robust increases in firing of genetically identified pyramidal neurons. These mouse lines are valuable tools for investigating the molecular, cellular, pharmacological, physiological, behavioral and other mechanisms of psychedelic actions in vivo. Chiu et al. have developed engineered HTR2A mouse lines enabling in vivo mapping, targeting and modulation of receptor-expressing neurons and validated their utility across biochemical, electrophysiological and behavioral studies of psychedelic mechanisms.
Classical psychedelics exert hallucinogenic and therapeutic effects primarily through activation of serotonin 2 A receptor (5-HT2AR), offering promise as transformative treatments for neuropsychiatric disorders. However, their concurrent activation of 5-HT2BR—associated with cardiac valvulopathy—raises serious safety c...
This thesis is to investigate whether psychedelics, and particularly the potent psychoplastogen LSD, can stimulate neuroplasticity in humans and consists of three papers exploring this question from different angles.
Overall, the existing findings support TAAR1 as a therapeutic target for treatment of substance use disorders, however, translating these findings into effective human pharmacotherapies requires navigating ligand-specific effects and pharmacokinetic demands and defining the role of human TAAR1 genetic diversity in ther...
Samantha M. Rios, S. Shabani, T. J. Phillips· Handbook of Experimental Pha...· 0 citations
Preliminary findings suggest that the in vitro stress protocol induces structural and synaptic alterations, and that ketamine rapidly affects expression of several proteins involved in synaptic plasticity.
N. Nicosia, J. Mingardi, G. Terribile et al.· International Journal of Neu...· 0 citations
Findings suggest that while acute LSD, at high doses decreases decreased theta, beta, and gamma power and 5-HT firing activity, after repeated LSD may counteract stress-induced anxiety by enhancing cortical synaptic plasticity and serotonergic neurotransmission, potentially via 5-HT₁A receptor desensitization at the pr...
G. Gobbi· International Journal of Neu...· 0 citations
A chemogenetic approach is employed to chronically silence LC noradrenergic neurons in a male mouse model of neuropathic pain induced by spared nerve injury and results suggest a therapeutic relevance of C15OXA in neuropathic pain and support a possible involvement of the LC in mediating its behavioral and molecular ef...
F. Ricciardi, M. Llorca-Torralba, L. Luongo et al.· Neuropharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.